Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches
Clinical trial NCT01035983 · COMPLETED
Trial details
- NCT number
- NCT01035983
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2005-06-01
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.